Inflammatory myofibroblastic tumor arising from soft tissues of extremities harboring a novel CLIP2-ALK fusion

被引:3
|
作者
Ding, Ru [1 ]
Li, Xiao [1 ]
Zhu, Xiao-Mei [1 ]
Song, Quo-Xing [1 ]
Fan, Qin-He [1 ]
Zhang, Zhi-Hong [1 ]
Gong, Qi-Xing [1 ]
机构
[1] Nanjing Med Univ, Dept Pathol, Affiliated Hosp 1, 300 Guangzhou Rd, Nanjing 210029, Peoples R China
关键词
ALK; CLIP2; inflammatory myofibroblastic tumor; somatic soft tissue; ANAPLASTIC LYMPHOMA-KINASE; RET GENE FUSIONS; ALK; REARRANGEMENTS; PSEUDOTUMOR; ROS1;
D O I
10.1111/pin.12988
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
A 34-year-old Chinese woman found a lump in her left leg for more than 3 weeks without any discomfort. Grossly, the tumor was relatively well delineated with focal infiltration. Histopathologic evaluation showed a compact fascicular spindle cell proliferation with variable myxoid and collagenous stroma and scattered inflammatory infiltrate. Immunohistochemically, the tumor cells showed positive expression of ALKD5F3 and SMA and negative expression of CD34, desmin, and cytokeretin. Fluorescence in situ hybridization analysis of the ALK locus showed break-apart signals in 20% of tumor cells, and DNA sequencing discovered a novel CLIP2-ALK fusion gene. The lesion was diagnosed as an inflammatory myofibroblastic tumor (IMT). To the best of our knowledge, this is the first case with CLIP2-ALK gene fusion in the somatic soft tissue IMTs.
引用
收藏
页码:798 / 803
页数:6
相关论文
共 36 条
  • [21] Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1-ALK fusion: a case report
    Honda, Kazunori
    Kadowaki, Shigenori
    Kato, Kyoko
    Hanai, Nobuhiro
    Hasegawa, Yasuhisa
    Yatabe, Yasushi
    Muro, Kei
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (04) : 791 - 795
  • [22] Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1–ALK fusion: a case report
    Kazunori Honda
    Shigenori Kadowaki
    Kyoko Kato
    Nobuhiro Hanai
    Yasuhisa Hasegawa
    Yasushi Yatabe
    Kei Muro
    Investigational New Drugs, 2019, 37 : 791 - 795
  • [23] A Novel CASC15-ALK and TFG-ROS1 Fusion Observed in Uterine Inflammatory Myofibroblastic Tumor
    Chang, Bin
    Wang, Zhe
    Ren, Min
    Yao, Qianlan
    Zhao, Lu
    Zhou, Xiaoyan
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2023, 42 (05) : 451 - 459
  • [24] Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor
    Cools, J
    Wlodarska, I
    Somers, R
    Mentens, N
    Pedeutour, F
    Maes, B
    De Wolf-Peeters, C
    Pauwels, P
    Hagemeijer, A
    Marynen, P
    GENES CHROMOSOMES & CANCER, 2002, 34 (04): : 354 - 362
  • [25] Case Report: Efficacy of ensartinib treatment in pulmonary inflammatory myofibroblastic tumor with a rare GCC2-ALK fusion
    He, Wenguang
    Ji, Xiao
    Song, Congcong
    Song, Shanshan
    Liu, Lixia
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [26] STUMP un“stumped”: anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion
    Vivek Subbiah
    Caitlin McMahon
    Shreyaskumar Patel
    Ralph Zinner
    Elvio G Silva
    Julia A. Elvin
    Ishwaria M. Subbiah
    Chimela Ohaji
    Dhakshina Moorthy Ganeshan
    Deepa Anand
    Charles F. Levenback
    Jenny Berry
    Tim Brennan
    Juliann Chmielecki
    Zachary R. Chalmers
    John Mayfield
    Vincent A. Miller
    Philip J. Stephens
    Jeffrey S. Ross
    Siraj M. Ali
    Journal of Hematology & Oncology, 8
  • [27] STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion
    Subbiah, Vivek
    McMahon, Caitlin
    Patel, Shreyaskumar
    Zinner, Ralph
    Silva, Elvio G.
    Elvin, Julia A.
    Subbiah, Ishwaria M.
    Ohaji, Chimela
    Ganeshan, Dhakshina Moorthy
    Anand, Deepa
    Levenback, Charles F.
    Berry, Jenny
    Brennan, Tim
    Chmielecki, Juliann
    Chalmers, Zachary R.
    Mayfield, John
    Miller, Vincent A.
    Stephens, Philip J.
    Ross, Jeffrey S.
    Ali, Siraj M.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2015, 8
  • [28] Uterine inflammatory myofibroblastic tumor harboring novel NUDCD3-ROS1 and NRP2-ALK fusions: clinicopathologic features of 4 cases and literature review
    Lili Zhang
    Lijuan Luan
    Licheng Shen
    Ruqun Xue
    Jie Huang
    Jieakesu Su
    Yufeng Huang
    Yifan Xu
    Xiang Wang
    Yang Shao
    Yuan Ji
    Chen Xu
    Yingyong Hou
    Virchows Archiv, 2023, 482 : 567 - 580
  • [29] Uterine inflammatory myofibroblastic tumor harboring novel NUDCD3-ROS1 and NRP2-ALK fusions: clinicopathologic features of 4 cases and literature review
    Zhang, Lili
    Luan, Lijuan
    Shen, Licheng
    Xue, Ruqun
    Huang, Jie
    Su, Jieakesu
    Huang, Yufeng
    Xu, Yifan
    Wang, Xiang
    Shao, Yang
    Ji, Yuan
    Xu, Chen
    Hou, Yingyong
    VIRCHOWS ARCHIV, 2023, 482 (03) : 567 - 580
  • [30] Case Report: Early Distant Metastatic Inflammatory Myofibroblastic Tumor Harboring EML4-ALK Fusion Gene: Study of Two Typical Cases and Review of Literature
    Han, Qianqian
    He, Xin
    Cui, Lijuan
    Qiu, Yan
    Li, Yuli
    Chen, Huijiao
    Zhang, Hongying
    FRONTIERS IN MEDICINE, 2022, 9